Back to Search
HELEN HESLOP, MD
MD
Pediatric Hematology & Oncology Physician
NPI: 1912087271IndividualAccepts Medicare
Specialties, Licenses & Credentials
Pediatric Hematology & Oncology PhysicianPrimary
Pediatrics — Pediatric Hematology-Oncology
Code: 2080P0207X
L1610(TX)
Education
OTHER
Class of 1980
Research & Publications (20)
Biology and treatment of Epstein-Barr virus-associated non-Hodgkin lymphomas.
PMID 16304390·Hematology Am Soc Hematol Educ Program·2005
8-other
Cellular therapy of Epstein-Barr-virus-associated post-transplant lymphoproliferative disease.
PMID 15498712·Best Pract Res Clin Haematol·2004
6-review
Immunotherapy of hematologic malignancy.
PMID 14633789·Hematology Am Soc Hematol Educ Program·2003
6-review
Immune therapy for EBV infections after hemopoietic stem-cell transplant.
PMID 12473214·Cytotherapy·2002
6-review
Administration of neomycin resistance gene-marked EBV-specific cytotoxic T-lymphocytes as therapy for patients receiving a bone marrow transplant for relapsed EBV-positive Hodgkin disease.
PMID 10910143·Hum Gene Ther·2000
3-trial
Immunotherapy for osteosarcoma: genetic modification of T cells overcomes low levels of tumor antigen expression.
PMID 19532139·Mol Ther·2009
7-preclinical
Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes.
PMID 19443656·Blood·2009
8-other
Genetic manipulation of tumor-specific cytotoxic T lymphocytes to restore responsiveness to IL-7.
PMID 19259067·Mol Ther·2009
7-preclinical
T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model.
PMID 19377047·Blood·2009
7-preclinical
Enhancing the in vivo expansion of adoptively transferred EBV-specific CTL with lymphodepleting CD45 monoclonal antibodies in NPC patients.
PMID 18971421·Blood·2009
3-trial
Nucleofection of DCs to generate Multivirus-specific T cells for prevention or treatment of viral infections in the immunocompromised host.
PMID 19584818·Mol Ther·2009
8-other
Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma.
PMID 18978797·Nat Med·2008
8-other
Successful treatment of stem cell graft failure in pediatric patients using a submyeloablative regimen of campath-1H and fludarabine.
PMID 18940685·Biol Blood Marrow Transplant·2008
4-observational
Comparable outcome of alternative donor and matched sibling donor hematopoietic stem cell transplant for children with acute lymphoblastic leukemia in first or second remission using alemtuzumab in a myeloablative conditioning regimen.
PMID 18940679·Biol Blood Marrow Transplant·2008
4-observational
Adoptive cellular therapy with T cells specific for EBV-derived tumor antigens.
PMID 19255606·Update Cancer Ther·2008
8-other
Hematopoietic stem cell transplantation in patients with sporadic amyotrophic lateral sclerosis.
PMID 18936424·Neurology·2008
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6701 FANNIN ST
HOUSTON, TX 77030 - Phone
- (832) 822-4240
Quick Facts
- NPI
- 1912087271
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 46
- Publications
- 20
Are you this provider?
Claim Your Profile